CAIM
ABBV icon

Catherine Avery Investment Management’s AbbVie ABBV Stock Holding History

Catherine Avery Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.4K Buy
117
+1
+0.9% +$215 0.01% 83
2026
Q1 		$25.3K Sell
116
-40
-26% -$8.87K 0.01% 75
2025
Q4 		$35.7K Sell
156
-106
-40% -$24.1K 0.02% 73
2025
Q3 		$60.6K Buy
262
+1
+0.4% +$204 0.04% 67
2025
Q2 		$48.5K Hold
261
– – 0.04% 66
2025
Q1 		$54.6K Buy
261
+1
+0.4% +$194 0.05% 68
2024
Q4 		$46.2K Buy
+260
New +$47.8K 0.04% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Catherine Avery Investment Management's ABBV Position: Q2 2026 in Review

Catherine Avery Investment Management increased its AbbVie (ABBV) stake by 0.86% in Q2 2026, buying an estimated $215 and bringing the position to 117 shares worth $29.4K. The position accounts for 0.01% of the portfolio, ranked #83.

Catherine Avery Investment Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $60.6K in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Catherine Avery Investment Management held 117 shares of AbbVie worth $29.4K as of Q2 2026.
  • Catherine Avery Investment Management bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.01% of Catherine Avery Investment Management's portfolio in Q2 2026, its #83 holding.
  • Catherine Avery Investment Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Catherine Avery Investment Management's AbbVie position peaked at $60.6K in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Catherine Avery Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.